Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
Q4 2025 Earnings Call September 25, 2025 8:30 AM EDTCompany ParticipantsAdam Berry - Senior Vice President of Investor Relations ...